Literature DB >> 11229859

Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia.

R H Yolken1, S Bachmann, I Ruslanova, E Lillehoj, G Ford, E F Torrey, J Schroeder, I Rouslanova.   

Abstract

We employed enzyme immunoassay (EIA) and Western blotting techniques to measure the level of antibodies to Toxoplasma gondii proteins in serum samples from 38 individuals undergoing their first episode of schizophrenia and from a group of matched control subjects. We found that the individuals with first-episode schizophrenia had significantly increased levels of IgG, IgM, and IgA class antibodies to Toxoplasma proteins, as compared with the control subjects.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11229859     DOI： 10.1086/319221

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  47 in total

1.  Molecular cloning and characterization of an SRCAP chromatin remodeling homologue in Toxoplasma gondii.

Authors:  William J Sullivan; M Alexandra Monroy; Wolfgang Bohne; Karuna C Nallani; John Chrivia; Peter Yaciuk; Charles K Smith; Sherry F Queener
Journal:  Parasitol Res       Date:  2003-01-28       Impact factor: 2.289

2.  Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.

Authors:  Christopher P Hencken; Lorraine Jones-Brando; Claudia Bordón; Remo Stohler; Bryan T Mott; Robert Yolken; Gary H Posner; Lauren E Woodard
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

3.  Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis.

Authors:  E Fuller Torrey; John J Bartko; Zhao-Rong Lun; Robert H Yolken
Journal:  Schizophr Bull       Date:  2006-11-03       Impact factor: 9.306

4.  Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour.

Authors:  J P Webster; P H L Lamberton; C A Donnelly; E F Torrey
Journal:  Proc Biol Sci       Date:  2006-04-22       Impact factor: 5.349

Review 5.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 6.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

7.  Serological and molecular diagnosis of Toxoplasma gondii in patients with schizophrenia.

Authors:  Adel Ebrahimzadeh; Mehdi Khoshsima Shahraki; Azad Mohammadi
Journal:  J Parasit Dis       Date:  2018-03-08

8.  Does Systemic Inflammation Play a Role in Pediatric Psychosis?

Authors:  Tatiana Falcone; Erin Carlton; Catherine Lee; Mattia Janigro; Vince Fazio; Fernando Espi Forcen; Kathleen Franco; Damir Janigro
Journal:  Clin Schizophr Relat Psychoses       Date:  2013-03-14

9.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

10.  Seroepidemiology of human Toxoplasma gondii infection in China.

Authors:  Yue Xiao; Jigang Yin; Ning Jiang; Mei Xiang; Lili Hao; Huijun Lu; Hong Sang; Xianying Liu; Huiji Xu; Johan Ankarklev; Johan Lindh; Qijun Chen
Journal:  BMC Infect Dis       Date:  2010-01-07       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.